SynthesisEuropean journal of clinical pharmacology2023

Lenvatinib in the treatment of unresectable hepatocellular carcinoma: a systematic review of economic evaluations.

Ghader Mohammadnezhad et al.PubMed ↗Publisher ↗

No numbers read from the abstract.